EntryPoint Capital’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-29,815
Closed -$133K 856
2024
Q1
$133K Sell
29,815
-8,108
-21% -$36.2K 0.12% 274
2023
Q4
$122K Buy
+37,923
New +$122K 0.12% 278